Investigational Pneumonia Vaccine Study

Pneumonia is responsible for causing illness in millions of people every year. While many experience mild symptoms, those suffering from other chronic conditions are at a higher risk for severe sickness and hospitalization. Vaccines, such as the pneumonia vaccine, can help reduce your risk and lessen your symptoms should you get it.

Centricity Research is currently participating in an investigational pneumonia vaccine study at our Phoenix, Arizona location. 

Enroll Now

Investigational Pneumonia Vaccine Study

Vaccine research is essential to protecting our community. Centricity Research is currently participating in an investigational pneumonia vaccine study that seeks to evaluate V116 in pneumococcal vaccine-naïve adults with an increased risk for pneumococcal disease.  

We are specifically looking for volunteers who are:

• Have more than one of the following risk conditions for pneumococcal disease: diabetes, chronic liver disease, COPD, chronic heart disease, mild to moderate asthma, or chronic kidney disease 

 Study Duration: 6 months 

 Location: Centricity Research, 215 S. Power Road, Suite 207, Mesa, AZ 85206 

Learn more about this study and search protocol V116-008 at clinicaltrials.gov